Elena Urcelay
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 08, 2026
Mitochondrial function of peripheral lymphocytes: role on multiple sclerosis clinical subtypes.
Journal: Life sciences
Published: September 17, 2025
Mitochondrial Changes Induced by SGLT2i in Lymphocytes from Diabetic Kidney Transplant Recipients: A Pilot Study.
Journal: International journal of molecular sciences
Published: January 27, 2025
The Variant rs7665090 Is Associated With Interferon-Beta Response in Multiple Sclerosis Patients.
Journal: European journal of neurology
Published: December 24, 2024
First genome-wide association study reveals immune-mediated aetiopathology in idiopathic achalasia.
Journal: Gut
Published: December 03, 2024
Long-term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19.
Journal: Cell biology and toxicology
Published: August 23, 2024
Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production.
Journal: International journal of molecular sciences
Published: February 22, 2024
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis.
Journal: Clinical and translational medicine
Published: January 11, 2024
Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients.
Journal: Frontiers in immunology
Published: December 19, 2022
Integration of Multiple Interferometers in Highly Multiplexed Diagnostic KITs to Evaluate Several Biomarkers of COVID-19 in Serum.
Journal: Biosensors
Published: July 22, 2022
Last Updated: 09/26/2026